These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37208851)

  • 1. A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.
    Choi SM; Kang MJ; Kwon SH; Sim WY; Lew BL
    J Dermatol; 2023 Oct; 50(10):1335-1338. PubMed ID: 37208851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Prognosis of Alopecia Totalis and Alopecia Universalis: A Longitudinal Study with More than 10 Years of Follow-Up: Better than Reported.
    Jang YH; Hong NS; Moon SY; Eun DH; Lee WK; Chi SG; Kim JY; Lee WJ; Lee SJ; Kim DW
    Dermatology; 2017; 233(2-3):250-256. PubMed ID: 28704810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
    Browne R; Stewart L; Williams HC
    Br J Dermatol; 2018 Sep; 179(3):609-614. PubMed ID: 29777625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUVA treatment of alopecia areata totalis and universalis: a retrospective study.
    Whitmont KJ; Cooper AJ
    Australas J Dermatol; 2003 May; 44(2):106-9. PubMed ID: 12752182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology.
    Taylor CR; Hawk JL
    Br J Dermatol; 1995 Dec; 133(6):914-8. PubMed ID: 8547044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia totalis and universalis long-term outcomes: a review.
    Burroway B; Griggs J; Tosti A
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):709-715. PubMed ID: 31593606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Relapse Rates Despite Early Intervention with Intravenous Methylprednisolone Pulse Therapy for Severe Childhood Alopecia Areata.
    Smith A; Trüeb RM; Theiler M; Hauser V; Weibel L
    Pediatr Dermatol; 2015; 32(4):481-7. PubMed ID: 25872976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed administration of corticosteroids in the treatment of alopecia areata.
    Sharma VK
    Int J Dermatol; 1996 Feb; 35(2):133-6. PubMed ID: 8850047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous methylprednisolone pulse therapy in severe alopecia areata.
    Senila SC; Danescu SA; Ungureanu L; Candrea E; Cosgarea RM
    Indian J Dermatol Venereol Leprol; 2015; 81(1):95. PubMed ID: 25566921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
    Chartaux E; Joly P
    Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis.
    Varghese SA; Nair SS; George AE; Yadev I
    Int J Trichology; 2023; 15(4):149-153. PubMed ID: 38765726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis.
    Cho HH; Jo SJ; Paik SH; Jeon HC; Kim KH; Eun HC; Kwon OS
    J Korean Med Sci; 2012 Jul; 27(7):799-802. PubMed ID: 22787378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical Trial.
    Joly P; Lafon A; Houivet E; Donnadieu N; Richard MA; Dupuy A; Delaporte E; Bernard P; Machet L; Tosti A; Del Marmol V; Grimalt R; de Viragh PA; Benichou J; Chosidow O; Assouly P; Reygagne P
    JAMA Dermatol; 2023 Apr; 159(4):403-410. PubMed ID: 36884234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E; Şentürk N
    Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata totalis and universalis: a multicenter review of 132 patients in Spain.
    Vañó-Galván S; Fernández-Crehuet P; Grimalt R; Garcia-Hernandez MJ; Rodrigues-Barata R; Arias-Santiago S; Molina-Ruiz A; Garcia-Lora E; Dominguez-Cruz J; Brugues A; Ferrando J; Serrano-Falcón C; Serrano S; Paoli J; Camacho F
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):550-556. PubMed ID: 27608049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients.
    Moussa A; Eisman S; Kazmi A; Poa J; Chitreddy V; Rathnayake D; Joseph S; Sinclair RD; Bhoyrul B
    J Am Acad Dermatol; 2023 May; 88(5):1194-1196. PubMed ID: 36623557
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
    Ricar J; Cetkovska P; Hordinsky M; Ricarova R
    Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.